- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/265 - Enterobacter (G)
Détention brevets de la classe C07K 14/265
Brevets de cette classe: 25
Historique des publications depuis 10 ans
|
3
|
2
|
3
|
2
|
4
|
1
|
2
|
2
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6494 |
8 |
| Ajinomoto Co., Inc. | 2299 |
2 |
| Medicinal Genomics Corporation | 52 |
2 |
| Curevac SE | 263 |
2 |
| ExxonMobil Research And Engineering Company | 2590 |
1 |
| Glaxosmithkline Biologicals S.A. | 1635 |
1 |
| The Chancellor, Masters and Scholars of The University of Oxford | 162 |
1 |
| Council of Scientific & Industrial Research | 1423 |
1 |
| National University Corporation Kagawa University | 211 |
1 |
| Regents of the University of Minnesota | 2683 |
1 |
| The Trustees of Princeton University | 1199 |
1 |
| The University Court of the University of Glasgow | 244 |
1 |
| University of Guelph | 356 |
1 |
| BGI Shenzhen | 499 |
1 |
| Transfert Plus Limited Partnership | 4 |
1 |
| Autres propriétaires | 0 |